查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496168

全球治疗药物市场（2024年版）：按分子类型、治疗领域、地区和国家分类的分析、市场考虑和预测（2020-2030年）

Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
出版日期: | 出版商: Azoth Analytics | 英文 224 Pages | 订单完成后即时交付

价格

2020年至2023年，全球治疗药物市场规模复合年增长率为6.61%。预计2023年市场规模为6869.7亿美元，2030年预计将达到11159亿美元。

癌症、心臟病、糖尿病和神经病变等慢性疾病正在推动市场发展。根据世界卫生组织（WHO）的报告，这些疾病是导致死亡和残疾的主要原因，占所有死亡的70%以上。这一增长是由于人口老化、不健康的生活方式和环境污染等因素造成的。

此外，预计到2050年，60岁及以上人口将达到20亿，人口迅速老化，阿兹海默症、失智症、骨质疏鬆症等与老龄化相关的疾病日益普遍，治疗需求日益增加。此外，老年人更容易患多种慢性疾病，因此需要开发联合治疗和有效的管理策略。

展望未来，由于技术创新、个人化医疗以及对成本效益的日益关注，全球治疗市场预计将继续成长，为市场参与企业创造新的机会。此外，抗生素抗药性日益严重的威胁强烈表明需要新的抗菌疗法。

该报告审视了全球治疗药物市场，并提供了包括市场规模和预测、区域和细分市场分析以及主要趋势和机会在内的资讯。

目录

第一章 市集背景

  • 产品范围和产品前景
  • 执行摘要
  • 调查方法

第二章 分析师建议

  • 个人化医疗
  • 奈米医学标靶治疗

第三章全球治疗​​药物市场：表现与预测

  • 宏观经济因素对治疗药物市场的影响分析
  • 全球生物技术支出
  • 欧洲、美国、日本和中国的医药研发支出
  • 有效 API DMF 总数：依国家分类
  • 最省钱的 10 种非专利产品 (2022)
  • 全球治疗药物市场：仪表板
  • 全球治疗药物市场：市场规模与复合年增长率（2020-2030）
  • 全球治疗药物市场：市场金额评估
  • 评估 COVID-19 对治疗药物市场的影响
  • 全球治疗药物市场细分：按分子类型
    • 全球治疗药物市场：按分子类型概述
    • 全球治疗药物市场吸引力指数：依分子类型
    • 全球治疗药物市场规模：生技药品、生物相似药（金额）（2020-2030）
    • 全球治疗药物市场规模：小分子（金额）（2020-2030）
  • 全球治疗方法市场细分：按治疗领域
    • 全球治疗药物市场：按治疗领域概述
    • 全球治疗药物市场吸引力指数：依治疗领域
    • 全球治疗药物市场规模：肿瘤（金额）（2020-2030）
    • 全球治疗药物市场规模：感染疾病（金额）（2020-2030）
    • 全球治疗药物市场规模：心血管疾病（金额）（2020-2030）
    • 全球治疗药物市场规模：糖尿病/肥胖（金额）（2020-2030）
    • 全球治疗药物市场规模：免疫学（金额）（2020-2030）
    • 全球治疗药物市场规模：其他治疗领域（金额）（2020-2030）

第四章 全球治疗药物市场、区域分析

  • 研究的区域范围
  • 区域简介

第五章北美与南美治疗药物市场：表现与预测

  • 美洲治疗市场：简介
  • 美洲治疗药物市场：市场规模与复合年增长率（2020-2030）
  • 美洲治疗药物市场：主要驱动因素
  • 美洲治疗药物市场：細項分析
  • 按分子类型分類的美洲治疗药物市场细分
  • 美洲治疗药物市场细分：治疗领域
  • 按国家/地区分類的美洲治疗药物市场细分
    • 美洲治疗药物市场：按国家划分，概述
    • 美国治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 加拿大治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 其他美洲治疗药物市场：市场规模和复合年增长率（2020-2030）

第六章欧洲治疗药物市场：表现与预测

  • 欧洲治疗市场：概况
  • 欧洲治疗药物市场：市场规模与复合年增长率（2020-2030）
  • 欧洲治疗药物市场：主要驱动因素
  • 欧洲治疗药物市场：細項分析
  • 欧洲治疗药物市场细分：按分子类型
  • 欧洲治疗药物市场细分：依治疗领域
  • 欧洲治疗药物市场细分：按国家/地区
    • 欧洲治疗药物市场：按国家划分，概述
    • 德国治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 英国治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 法国治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 义大利治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 西班牙治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 其他欧洲治疗药物市场：市场规模和复合年增长率（2020-2030）

第七章亚太治疗药物市场：表现与预测

  • 亚太治疗市场：概况
  • 亚太地区治疗药物市场：市场规模与复合年增长率（2020-2030）
  • 亚太地区治疗药物市场：主要驱动因素
  • 亚太地区治疗药物市场：細項分析
  • 亚太地区治疗药物市场细分：依分子类型
  • 按治疗领域分類的亚太地区治疗药物市场细分
  • 按国家/地区分類的亚太地区治疗药物市场细分
    • 亚太地区治疗药物市场：按国家划分，概述
    • 中国治疗药物市场：市场规模及复合年增长率（2020-2030）
    • 日本治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 印度治疗药物市场：市场规模与复合年增长率（2020-2030）
    • 亚太地区其他治疗药物市场：市场规模与复合年增长率（2020-2030）

第八章中东和非洲的治疗药物市场：实际结果和预测

  • 中东和非洲治疗药物市场：简介
  • 中东和非洲治疗药物市场：市场规模和复合年增长率（2020-2030）
  • 中东和非洲治疗药物市场：主要驱动因素
  • 中东和非洲治疗药物市场：細項分析
  • 中东和非洲治疗药物市场细分：按分子类型
  • 中东和非洲治疗药物市场细分：按治疗领域

第九章市场动态

  • 评估市场动态对治疗药物市场的影响
  • 促进因素
  • 抑制因素
  • 趋势

第10章产业生态系分析

  • 波特分析

第十一章竞争定位

  • 企业产品定位
  • 市场地位矩阵
  • 治疗药物市场市场占有率分析
  • 公司简介
    • Sanofi
    • Cipla
    • Pfizer
    • GSK PLC
    • Novartis AG
    • Bayer AG
    • Merck & Co., Inc.
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Gilead Sciences, Inc.

第十二章 关于我们公司、免责声明

Executive Summary

Azoth Analytics has released a research report titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, Cardiovascular Disease, Diabetes/Obesity, Immunology, Other Therapeutic Areas) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Therapeutics market showcased growth at a CAGR of 6.61% during 2020-2023. The market was valued at USD 686.97 Billion in 2023 which is expected to reach USD 1115.90 Billion in 2030.

Chronic diseases like cancer, heart disease, diabetes, and neurological disorders are fueling the global therapeutics market. The World Health Organization (WHO) reports these conditions as the leading cause of death and disability, accounting for over 70% of all deaths. This rise is attributed to factors like an aging population, unhealthy lifestyles, and environmental pollution.

Furthermore, the rapidly aging population, with the number of people over 60 expected to reach 2 billion by 2050, creates a growing demand for treatments for age-related conditions like Alzheimer's, dementia, and osteoporosis. Additionally, the elderly are more prone to multiple chronic conditions, necessitating the development of combination therapies and effective management strategies.

Looking ahead, the global therapeutics market is poised for continued growth due to the increasing focus on innovation, personalized medicine, and cost-effectiveness, creating new opportunities for market players. Additionally, the growing threat of antibiotic resistance underscores the need for novel antimicrobial therapies.

Scope of the Report:

  • The report analyses the Therapeutics Market by Value (USD Billion).
  • The report analyses the Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The report presents the analysis of Therapeutics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Therapeutics Market By Molecule Type (Biologics and Biosimilars, Small Molecules)
  • The report analyses the Therapeutics Market By Therapeutic Area (Oncology, Infectious Disease, and Cardiovascular Disease, Diabetes/Obesity, Immunology, and Other Therapeutic Areas).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Molecule Type and By Therapeutic Areas.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Cipla, Pfizer, GSK PLC, Novartis AG, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche AG, Abbott Laboratories and Gilead Sciences, Inc.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Analyst Recommendations

  • 2.1 Personalized Medicine
  • 2.2 Targeted therapy with Nanomedicine

3. Global Therapeutics Market: Historic and Forecast

  • 3.1 Impact Analysis of Macro Economic Factors on Therapeutics Market
  • 3.2 Global biotech spending
  • 3.3 Pharmaceutical R&D expenditure in Europe, USA, Japan and China
  • 3.4 Total Active API DMFs, by country
  • 3.5 Top 10 Generic Products with Greatest Savings in 2022
  • 3.6 Global Therapeutics Market: Dashboard
  • 3.7 Global Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 3.8 Global Therapeutics Market: Market Value Assessment
  • 3.9 Assessment Degree of Impact of COVID-19 on Therapeutics Market
  • 3.10 Global Therapeutics Market Segmentation: By Molecule Type
    • 3.10.1 Global Therapeutics Market, By Molecule Type Overview
    • 3.10.2 Global Therapeutics Market Attractiveness Index, By Molecule Type
    • 3.10.3 Global Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.4 Global Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11 Global Therapeutics Market Segmentation: By Therapeutic Area
    • 3.11.1 Global Therapeutics Market, By Therapeutic Area Overview
    • 3.11.2 Global Therapeutics Market Attractiveness Index, By Therapeutic Area
    • 3.11.3 Global Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.4 Global Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.5 Global Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.6 Global Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.7 Global Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.8 Global Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Therapeutics Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Therapeutics Market: Historic and Forecast

  • 5.1 Americas Therapeutics Market: Snapshot
  • 5.2 Americas Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 5.3 Americas Therapeutics Market: Key Factors
  • 5.4 Americas Therapeutics Market: Segment Analysis
  • 5.5 Americas Therapeutics Market Segmentation: By Molecule Type
    • 5.5.1 Americas Therapeutics Market, By Molecule Type Overview
    • 5.5.2 Americas Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.5.3 Americas Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6 Americas Therapeutics Market Segmentation: Therapeutic Area
    • 5.6.1 Americas Therapeutics Market, By Therapeutic Area Overview
    • 5.6.2 Americas Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.3 Americas Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.4 Americas Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.5 Americas Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.6 Americas Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.7 Americas Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7 Americas Therapeutics Market Segmentation: By Country
    • 5.7.1 Americas Therapeutics Market, by Country Overview
    • 5.7.2 United States Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.7.2.1 United States Therapeutics Market, By Molecule Type
      • 5.7.2.2 United States Therapeutics Market, By Therapeutic Area
    • 5.7.3 Canada Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.7.3.1 Canada Therapeutics Market, By Molecule Type
      • 5.7.3.2 Canada Therapeutics Market, By Therapeutic Area
    • 5.7.4 Rest of Americas Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.7.4.1 Rest of Americas Therapeutics Market, By Molecule Type
      • 5.7.4.2 Rest of Americas Therapeutics Market, By Therapeutic Area

6. Europe Therapeutics Market: Historic and Forecast

  • 6.1 Europe Therapeutics Market: Snapshot
  • 6.2 Europe Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 6.3 Europe Therapeutics Market: Key Factors
  • 6.4 Europe Therapeutics Market: Segment Analysis
  • 6.5 Europe Therapeutics Market Segmentation: By Molecule Type
    • 6.5.1 Europe Therapeutics Market, By Molecule Type Overview
    • 6.5.2 Europe Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.5.3 Europe Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6 Europe Therapeutics Market Segmentation: By Therapeutic Area
    • 6.6.1 Europe Therapeutics Market, By Therapeutic Area Overview
    • 6.6.2 Europe Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.4 Europe Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.5 Europe Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.6 Europe Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.7 Europe Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7 Europe Therapeutics Market Segmentation: By Country
    • 6.7.1 Europe Therapeutics Market, by Country Overview
    • 6.7.2 Germany Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.2.1 Germany Therapeutics Market, By Molecule Type
      • 6.7.2.2 Germany Therapeutics Market, By Therapeutic Area
    • 6.7.3 United Kingdom Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.3.1 United Kingdom Therapeutics Market, By Molecule Type
      • 6.7.3.2 United Kingdom Therapeutics Market, By Therapeutic Area
    • 6.7.4 France Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.4.1 France Therapeutics Market, By Molecule Type
      • 6.7.4.2 France Therapeutics Market, By Therapeutic Area
    • 6.7.5 Italy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.5.1 Italy Therapeutics Market, By Molecule Type
      • 6.7.5.2 Italy Therapeutics Market, By Therapeutic Area
    • 6.7.6 Spain Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.6.1 Spain Therapeutics Market, By Molecule Type
      • 6.7.6.2 Spain Therapeutics Market, By Therapeutic Area
    • 6.7.7 Rest of Europe Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.7.1 Rest of Europe Therapeutics Market, By Molecule Type
      • 6.7.7.2 Rest of Europe Therapeutics Market, By Therapeutic Area

7. Asia Pacific Therapeutics Market: Historic and Forecast

  • 7.1 Asia Pacific Therapeutics Market: Snapshot
  • 7.2 Asia Pacific Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 7.3 Asia Pacific Therapeutics Market: Key Factors
  • 7.4 Asia Pacific Therapeutics Market: Segment Analysis
  • 7.5 Asia Pacific Therapeutics Market Segmentation: By Molecule Type
    • 7.5.1 Asia Pacific Therapeutics Market, By Molecule Type Overview
    • 7.5.2 Asia Pacific Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.5.3 Asia Pacific Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6 Asia Pacific Therapeutics Market Segmentation: By Therapeutic Area
    • 7.6.1 Asia Pacific Therapeutics Market, By Therapeutic Area Overview
    • 7.6.2 Asia Pacific Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.4 Asia Pacific Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.5 Asia Pacific Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.6 Asia Pacific Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.7 Asia Pacific Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7 Asia Pacific Therapeutics Market Segmentation: By Country
    • 7.7.1 Asia Pacific Therapeutics Market, by Country Overview
    • 7.7.2 China Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.2.1 China Therapeutics Market, By Molecule Type
      • 7.7.2.2 China Therapeutics Market, By Therapeutic Area
    • 7.7.3 Japan Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.3.1 Japan Therapeutics Market, By Molecule Type
      • 7.7.3.2 Japan Therapeutics Market, By Therapeutic Area
    • 7.7.4 India Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.4.1 India Therapeutics Market, By Molecule Type
      • 7.7.4.2 India Therapeutics Market, By Therapeutic Area
    • 7.7.5 Rest of Asia Pacific Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.5.1 Rest of Asia Pacific Therapeutics Market, By Molecule Type
      • 7.7.5.2 Rest of Asia Pacific Therapeutics Market, By Therapeutic Area

8. Middle East and Africa Therapeutics Market: Historic and Forecast

  • 8.1 Middle East and Africa Therapeutics Market: Snapshot
  • 8.2 Middle East and Africa Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 8.3 Middle East and Africa Therapeutics Market: Key Factors
  • 8.4 Middle East and Africa Therapeutics Market: Segment Analysis
  • 8.5 Middle East and Africa Therapeutics Market Segmentation: By Molecule Type
    • 8.5.1 Middle East and Africa Therapeutics Market, By Molecule Type Overview
    • 8.5.2 Middle East and Africa Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.5.3 Middle East and Africa Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6 Middle East and Africa Therapeutics Market Segmentation: By Therapeutic Area
    • 8.6.1 Middle East and Africa Therapeutics Market, By Therapeutic Area Overview
    • 8.6.2 Middle East and Africa Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.4 Middle East and Africa Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.5 Middle East and Africa Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.6 Middle East and Africa Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.7 Middle East and Africa Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

  • 9.1 Impact assessment of Market Dynamics on Therapeutics Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter Analysis

11. Competitive Positioning

  • 11.1 Companies Product Positioning
  • 11.2 Market Position Matrix
  • 11.3 Market Share Analysis of Therapeutics Market
  • 11.4 Company Profiles
    • 11.4.1 Sanofi
    • 11.4.2 Cipla
    • 11.4.3 Pfizer
    • 11.4.4 GSK PLC
    • 11.4.5 Novartis AG
    • 11.4.6 Bayer AG
    • 11.4.7 Merck & Co., Inc.
    • 11.4.8 F. Hoffmann-La Roche AG
    • 11.4.9 Abbott Laboratories
    • 11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer

List of Figures

  • Figure 1: Global biotech spending
  • Figure 2: Pharmaceutical R&D expenditure in Europe, USA, Japan and China ( Million, 2020 constant exchange rate*)
  • Figure 3: Total Active API DMFs, by country, as of 2021
  • Figure 4: Global Therapeutics Market Size, By Value, 2020-2023 (USD Billion)
  • Figure 5: Global Therapeutics Market Size, By Value, 2024-2030 (USD Billion)
  • Figure 6: Global Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 7: Market Attractiveness Analysis of Therapeutics Market, By Molecule Type (2025-2030)
  • Figure 8: Global Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 9: Global Therapeutics Market Absolute Opportunity, By Biologics and Biosimilars, 2020-2030 (USD Billion)
  • Figure 10: Global Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 11: Global Therapeutics Market Absolute Opportunity, By Small Molecules, 2020-2030 (USD Billion)
  • Figure 12: Market Attractiveness Analysis of Therapeutics Market, By Therapeutic Area (2025-2030)
  • Figure 13: Global Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 14: Global Therapeutics Market Absolute Opportunity, By Oncology, 2020-2030 (USD Billion)
  • Figure 15: Global Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 16: Global Therapeutics Market Absolute Opportunity, By Infectious Disease, 2020-2030 (USD Billion)
  • Figure 17: Global Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 18: Global Therapeutics Market Absolute Opportunity, By Cardiovascular Disease, 2020-2030 (USD Billion)
  • Figure 19: Global Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 20: Global Therapeutics Market Absolute Opportunity, By Diabetes/Obesity, 2020-2030 (USD Billion)
  • Figure 21: Global Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 22: Global Therapeutics Market Absolute Opportunity, By Immunology, 2020-2030 (USD Billion)
  • Figure 23: Global Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 24: Global Therapeutics Market Absolute Opportunity, By Other Therapeutic Areas, 2020-2030 (USD Billion)
  • Figure 25: Americas Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 26: Americas Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 27: Americas Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 28: Americas Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 29: Americas Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 30: Americas Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 31: Americas Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 32: Americas Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 33: Americas Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 34: Americas Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 35: United States Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 36: United States Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 37: United States Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 38: United States Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 39: Canada Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 40: Canada Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 41: Canada Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 42: Canada Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 43: Rest of Americas Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 44: Rest of Americas Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 45: Rest of Americas Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 46: Rest of Americas Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 47: Europe Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 48: Europe Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 49: Europe Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 50: Europe Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 51: Europe Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 52: Europe Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 53: Europe Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 54: Europe Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 55: Europe Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 56: Europe Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 57: Germany Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 58: Germany Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 59: Germany Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 60: Germany Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 61: United Kingdom Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 62: United Kingdom Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 63: United Kingdom Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 64: United Kingdom Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 65: France Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 66: France Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 67: France Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 68: France Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 69: Italy Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 70: Italy Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 71: Italy Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 72: Italy Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 73: Spain Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 74: Spain Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 75: Spain Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 76: Spain Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 77: Rest of Europe Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 78: Rest of Europe Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 79: Rest of Europe Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 80: Rest of Europe Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 81: Asia Pacific Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 82: Asia Pacific Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 83: Asia Pacific Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 84: Asia Pacific Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 85: Asia Pacific Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 86: Asia Pacific Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 87: Asia Pacific Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 88: Asia Pacific Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 89: Asia Pacific Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 90: Asia Pacific Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 91: China Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 92: China Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 93: China Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 94: China Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 95: Japan Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 96: Japan Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 97: Japan Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 98: Japan Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 99: India Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 100: India Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 101: India Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 102: India Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 103: Rest of Asia Pacific Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 104: Rest of Asia Pacific Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 105: Rest of Asia Pacific Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 106: Rest of Asia Pacific Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 107: Middle East and Africa Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 108: Middle East and Africa Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 109: Middle East and Africa Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 110: Middle East and Africa Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 111: Middle East and Africa Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 112: Middle East and Africa Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 113: Middle East and Africa Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 114: Middle East and Africa Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 115: Middle East and Africa Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 116: Middle East and Africa Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 117: Market Share of Prominent Companies of Therapeutics Market, 2023 (%)
  • Figure 118: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 119: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 120: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 121: Cipla Revenues, 2020-2022 (USD Million)
  • Figure 122: Cipla Revenues, By Geographic Segments, 2022 (%)
  • Figure 123: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 124: Pfizer Revenues, By Business Segments, 2023 (%)
  • Figure 125: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
  • Figure 126: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 127: GSK PLC Revenue , By Business Segments, 2022 (%)
  • Figure 128: GSK PLC Revenue, By Geography Segment, 2022 (%)
  • Figure 129: Novartis Revenue, 2020-2022 (USD Million)
  • Figure 130: Novartis Revenue, By Business Segments, 2022 (%)
  • Figure 131: Novartis Revenue, By Geographical Segments, 2022 (%)
  • Figure 132: Bayer AG Revenues, 2020-2022 (USD Million)
  • Figure 133: Bayer AG Revenues, By Geographic Segments, 2022 (%)
  • Figure 134: Bayer AG Revenues, By Business Segments, 2022 (%)
  • Figure 135: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 121: Cipla Revenues, 2020-2022 (USD Million)
  • Figure 122: Cipla Revenues, By Geographic Segments, 2022 (%)
  • Figure 123: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 124: Pfizer Revenues, By Business Segments, 2023 (%)
  • Figure 125: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
  • Figure 126: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 127: GSK PLC Revenue , By Business Segments, 2022 (%)
  • Figure 128: GSK PLC Revenue, By Geography Segment, 2022 (%)
  • Figure 129: Novartis Revenue, 2020-2022 (USD Million)
  • Figure 130: Novartis Revenue, By Business Segments, 2022 (%)
  • Figure 131: Novartis Revenue, By Geographical Segments, 2022 (%)
  • Figure 132: Bayer AG Revenues, 2020-2022 (USD Million)
  • Figure 133: Bayer AG Revenues, By Geographic Segments, 2022 (%)
  • Figure 134: Bayer AG Revenues, By Business Segments, 2022 (%)
  • Figure 135: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Top 10 Generic Products with Greatest Savings in 2022

Table A3: United States Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A4: United States Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A5: United States Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A6: United States Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A7: Canada Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A8: Canada Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A9: Canada Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A10: Canada Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A11: Rest of Americas Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A12: Rest of Americas Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A13: Rest of Americas Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A14: Rest of Americas Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A15: Germany Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A16: Germany Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A17: Germany Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A18: Germany Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A19: United Kingdom Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A20: United Kingdom Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A21: United Kingdom Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A22: United Kingdom Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A23: France Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A24: France Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A25: France Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A26: France Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A27: Italy Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A28: Italy Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A29: Italy Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A30: Italy Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A31: Spain Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A32: Spain Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A33: Spain Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A34: Spain Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A35: Rest of Europe Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A36: Rest of Europe Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A37: Rest of Europe Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A38: Rest of Europe Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A39: China Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A40: China Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A41: China Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A42: China Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A43: Japan Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A44: Japan Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A45: Japan Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A46: Japan Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A47: India Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A48: India Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A49: India Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A50: India Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A51: Rest of Asia Pacific Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A52: Rest of Asia Pacific Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A53: Rest of Asia Pacific Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A54: Rest of Asia Pacific Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A55: Sanofi Key Financials, 2020-2022

Table A56: Cipla Key Financials, 2020-2022

Table A57: Pfizer Key Financials, 2021-2023

Table A58: GSK PLC Key Company Financials, 2020-2022

Table A59: Novartis Key Company Financials, 2020-2022

Table A60: Bayer AG Key Financials, 2020-2022

Table A61: Merck & Co., Inc. Key Financials, 2020-2022

Table A62: Roche Key Financials, 2021-2023

Table A63: Abbott Laboratories Key Financials, 2021-2023

Table A64: Gilead Sciences, Inc. Key Financials, 2021-2023